Developing and validating a trustworthy AI model for clinical practice [Video]

Leonardo Provenzano, MD, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy, discusses developing a reliable artificial intelligence (AI) model for clinical practice by integrating extensive data and validating it prospectively. This model aims to identify patient groups with varying prognoses, allowing for tailored treatment strategies, including potential escalation or de-escalation of therapies. This interview took place at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress in Berlin, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.